BCM Advisors’s Viemed Healthcare VMD Stock Holding History

BCM Advisors’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$277K	Hold	23,520	–	–	0.05%	70
2026 Q1	$223K	Hold	23,520	–	–	0.04%	71
2025 Q4	$172K	Hold	23,520	–	–	0.03%	70
2025 Q3	$161K	Hold	23,520	–	–	0.03%	70
2025 Q2	$147K	Hold	23,520	–	–	0.03%	65
2025 Q1	$173K	Buy	23,520 +2,250	+11%	+$17.7K	0.04%	65
2024 Q4	$177K	Hold	21,270	–	–	0.04%	66
2024 Q3	$181K	Hold	21,270	–	–	0.04%	63
2024 Q2	$146K	Hold	21,270	–	–	0.03%	68
2024 Q1	$172K	Hold	21,270	–	–	0.04%	63
2023 Q4	$169K	Hold	21,270	–	–	0.04%	62
2023 Q3	$148K	Hold	21,270	–	–	0.04%	60
2023 Q2	$196K	Hold	21,270	–	–	0.05%	59
2023 Q1	$229K	Buy	21,270 +4,500	+27%	+$39.2K	0.06%	57
2022 Q4	$130K	Hold	16,770	–	–	0.04%	61
2022 Q3	$109K	Hold	16,770	–	–	0.03%	59
2022 Q2	$131K	Hold	16,770	–	–	0.04%	56
2022 Q1	$86K	Hold	16,770	–	–	0.02%	53
2021 Q4	$78K	Buy	16,770 +6,025	+56%	+$33.6K	0.02%	53
2021 Q3	$61K	Hold	10,745	–	–	0.02%	52
2021 Q2	$70K	Buy	+10,745	New	+$93.1K	0.02%	53

Other funds holding VMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

BCM Advisors's VMD Position: Q2 2026 in Review

BCM Advisors held its Viemed Healthcare (VMD) position steady in Q2 2026 at 23,520 shares worth $277K. The position accounts for 0.05% of the portfolio, ranked #70.

BCM Advisors first reported a position in VMD in Q2 2021 and has held it in 21 quarters since. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

BCM Advisors held 23,520 shares of Viemed Healthcare worth $277K as of Q2 2026.
BCM Advisors left its Viemed Healthcare share count unchanged in Q2 2026.
Viemed Healthcare made up 0.05% of BCM Advisors's portfolio in Q2 2026, its #70 holding.
BCM Advisors first reported a position in Viemed Healthcare in Q2 2021 and has held it in 21 quarters since.
167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on BCM Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.